Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing
Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4